2017-10-12 (103 Days Old)Total Views: 12 | Last 7 Days: 1
(Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease.
CBC: 9 injured in apparent volcano eruption near Japan ski resort
ABC: Super Bowl brings Genie Bouchard and John Goehrke together again
Daily Mail: British lawyer's son at court for 'raping sleeping woman'
Daily Mail: Barnes leads Mavs past Wizards to snap skid
Daily Mail: Singer Neil Diamond diagnosed with Parkinson's disease,...
Daily Mail: Lisa Marie's estranged husband wants Presley to pay fees
Daily Mail: China criticizes Trump tariffs on solar, washing machines
Daily Mail: Mavs slow recent slide with season sweep of Wizards, 98-75
Daily Mail: Hyeon Chung v Tennys Sandgren match-up
CTV News: Massive fire at Port Coquitlam rail yard after fuel truck, train collide
CTV News: Evacuations ordered after fire breaks out at rail yard in Port Coquitlam, B.C.
Reuters: Mexico's Hoteles City Express to launch Fibra
AP: South Korea to start real-name trading of crypto currency
FOX: The Latest: Hundreds pack church, pray for girl who was shot
FOX: Rivendell Writers' Colony to close at the end of March
CBS: Pence says U.S. will move embassy to Jerusalem next year
ABC: China criticizes Trump tariffs on solar, washing machines
USA Today: Australian Open: Best of the quarterfinals
USA Today: Schroder scores 20 points, improving Hawks beat Jazz 104-90
USA Today: Varnado's putback lifts Troy over App State 81-79
ABC: South Korea to start real-name trading of crypto currency
Reuters: Tennis: Mertens stuns Svitolina to reach Melbourne semis
WashingtonPost: 9 injured in apparent volcano eruption near Japan ski resort